SCHEMBL10839780

SCHEMBL10839780

CC(=O)Cc1ccc(OC2CCCCC2)cc1

nearest known ligand 0.55

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
ACACB O00763 5/20 0.51
ALDH1A1 P00352 2/20 0.50
TSHR P16473 1/20 0.50
POLB P06746 1/20 0.50
EPHX2 P34913 1/20 0.49
PARP10 Q53GL7 1/20 0.49
GRM2 Q14416 1/20 0.48
NAAA Q02083 1/20 0.47
FFAR1 O14842 1/20 0.47
ALOX12 P18054 1/20 0.47
ACACA Q13085 1/20 0.46
FAAH O00519 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2347990 0.85 THRA (0.57) ACACBALDH1A1TSHREPHX2PARP10
SCHEMBL2347868 0.84 EPHX2 (0.54) ACACBALDH1A1TSHRPOLBEPHX2
SCHEMBL1929259 0.83 ACACB (0.50) ACACBPOLBGRM2
SCHEMBL13412909 0.83 THRA (0.55) ACACBALDH1A1TSHREPHX2PARP10
SCHEMBL2352038 0.83 ALDH1A1 (0.49) ACACBALDH1A1TSHREPHX2PARP10
SCHEMBL2348567 0.83 ALDH1A1 (0.49) ACACBALDH1A1TSHREPHX2PARP10
SCHEMBL2354923 0.81 PARP10 (0.50) ACACBALDH1A1TSHREPHX2PARP10
SCHEMBL4396801 0.81 NAAA (0.57) ACACBALDH1A1TSHRPARP10GRM2
SCHEMBL17610705 0.80 PARP10 (0.56) ACACBALDH1A1TSHREPHX2PARP10
SCHEMBL2350458 0.80 SIGMAR1 (0.46) ACACBALDH1A1TSHREPHX2PARP10

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4622342-A HYPOGLYCEMIC AGENTS, ANTIOBESITY BEECHAM GROUP P.L.C. (GB) 1986-11-11 US disclosed
EP-0070134-B1 SECONDARY PHENYL ETHANOL AMINES AND THEIR PHARMACEUTICAL USE BEECHAM GROUP PLC (GB) 1985-11-13 EP disclosed
EP-0070134-A1 Secondary phenyl ethanol amines and their pharmaceutical use BEECHAM GROUP PLC (GB) 1983-01-19 EP disclosed